September 2, 2017 - By wolcottdaily
Huber Capital Management Llc decreased Vodafone Group Plc New (VOD) stake by 22.56% reported in 2016Q4 SEC filing. Huber Capital Management Llc sold 28,500 shares as Vodafone Group Plc New (VOD)’s stock rose 16.21%. The Huber Capital Management Llc holds 97,818 shares with $2.39M value, down from 126,318 last quarter. Vodafone Group Plc New now has $77.24B valuation. The stock decreased 0.62% or $0.18 on September 1, reaching $28.85. About 2.96M shares traded or 14.29% up from the average. Vodafone Group Plc (ADR) (NASDAQ:VOD) has declined 13.23% since September 2, 2016 and is downtrending. It has underperformed by 29.93% the S&P500.
Cancer Genetics Incorporated (NASDAQ:CGIX) had a decrease of 5.76% in short interest. CGIX’s SI was 1.80M shares in September as released by FINRA. Its down 5.76% from 1.92M shares previously. With 61,300 avg volume, 29 days are for Cancer Genetics Incorporated (NASDAQ:CGIX)’s short sellers to cover CGIX’s short positions. The SI to Cancer Genetics Incorporated’s float is 12.88%. The stock increased 1.47% or $0.05 on September 1, reaching $3.45. About 55,864 shares traded. Cancer Genetics Inc (NASDAQ:CGIX) has risen 81.82% since September 2, 2016 and is uptrending. It has outperformed by 65.12% the S&P500.
Since May 16, 2017, it had 3 insider buys, and 0 insider sales for $457,563 activity. Another trade for 2,500 shares valued at $9,375 was bought by Harris Geoffrey E.. The insider PAPPAJOHN JOHN bought 100,000 shares worth $374,870.
Investors sentiment decreased to 1.17 in Q4 2016. Its down 1.54, from 2.71 in 2016Q3. It fall, as 5 investors sold Cancer Genetics Inc shares while 8 reduced holdings. 4 funds opened positions while 4 raised stakes. 1.94 million shares or 6.23% less from 2.07 million shares in 2016Q3 were reported. Sabby Ltd Liability Com holds 71,971 shares or 0.01% of its portfolio. The California-based Globeflex Capital Limited Partnership has invested 0% in Cancer Genetics Inc (NASDAQ:CGIX). Blackrock Institutional Trust Na has 12,424 shares for 0% of their portfolio. 310,400 are held by Renaissance Technology Limited Liability Corp. Tocqueville Asset L P has 0% invested in Cancer Genetics Inc (NASDAQ:CGIX). Perkins Incorporated reported 863,600 shares. Blackrock Fund reported 0% in Cancer Genetics Inc (NASDAQ:CGIX). Creative Planning has invested 0% in Cancer Genetics Inc (NASDAQ:CGIX). Blackrock Ltd Liability Corporation owns 2,086 shares. Diker Llc holds 0.02% in Cancer Genetics Inc (NASDAQ:CGIX) or 36,815 shares. Vanguard Grp invested in 0% or 225,093 shares. Geode Capital Mngmt Llc holds 41,243 shares or 0% of its portfolio. Northern Tru Corp accumulated 12,709 shares or 0% of the stock. Morgan Stanley holds 0% or 17,777 shares in its portfolio. Barclays Public Ltd Com holds 0% or 454 shares in its portfolio.
Among 6 analysts covering Cancer Genetics (NASDAQ:CGIX), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Cancer Genetics had 6 analyst reports since March 11, 2016 according to SRatingsIntel. As per Tuesday, August 15, the company rating was maintained by H.C. Wainwright. The stock has “Neutral” rating by Janney Capital on Friday, March 11. Rodman & Renshaw initiated Cancer Genetics Inc (NASDAQ:CGIX) on Monday, September 26 with “Buy” rating. Aegis Capital maintained the stock with “Buy” rating in Tuesday, March 15 report.
Cancer Genetics, Inc. is a United States company, which is engaged in the field of personalized medicine. The company has market cap of $68.28 million. The Firm offers diagnostic services and products that enable precision medicine in the field of oncology through molecular markers and diagnostics. It currently has negative earnings. The Firm offers a range of laboratory services that provide genomic and biomarker information.
Huber Capital Management Llc increased Teekay Tankers Ltd (NYSE:TNK) stake by 649,959 shares to 19.54M valued at $44.16M in 2016Q4. It also upped Kbr Inc (NYSE:KBR) stake by 351,791 shares and now owns 11.04M shares. Mercer Intl Inc (NASDAQ:MERC) was raised too.
Among 7 analysts covering Vodafone Group PLC (ADR) (NASDAQ:VOD), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Vodafone Group PLC (ADR) had 12 analyst reports since October 19, 2015 according to SRatingsIntel. The stock of Vodafone Group Plc (ADR) (NASDAQ:VOD) has “Hold” rating given on Tuesday, January 17 by HSBC. The company was initiated on Tuesday, January 3 by Standpoint Research. The firm has “Buy” rating given on Wednesday, April 20 by Bank of America. As per Thursday, June 1, the company rating was downgraded by Standpoint Research. The firm has “Neutral” rating by BNP Paribas given on Monday, November 21. The rating was upgraded by Goldman Sachs to “Buy” on Tuesday, January 10. The firm has “Hold” rating given on Tuesday, September 20 by Argus Research. On Monday, October 19 the stock rating was upgraded by Macquarie Research to “Outperform”. The rating was upgraded by Argus Research on Monday, June 12 to “Buy”. On Wednesday, January 25 the stock rating was downgraded by Bank of America to “Neutral”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.